Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02029443 |
Title | ACP-196, a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Acerta Pharma BV |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Boston | Massachusetts | 2215 | United States | Details | |
Research Site | New Hyde Park | New York | 11042 | United States | Details | |
Research Site | New York | New York | 10021 | United States | Details | |
Research Site | Columbus | Ohio | 43210 | United States | Details | |
Research Site | Fort Worth | Texas | 76104 | United States | Details | |
Research Site | Salt Lake City | Utah | 84112 | United States | Details | |
Research Site | Seattle | Washington | 98122 | United States | Details | |
Research Site | Tacoma | Washington | 98405 | United States | Details | |
Research Site | Milano | 20132 | Italy | Details | ||
Research Site | Leeds | LS9 7TF | United Kingdom | Details | ||
Research Site | London | SE5 9RS | United Kingdom | Details | ||
Research Site | Oxford | OX3 7LE | United Kingdom | Details |